Rick Buck: Vivek Subbiah on Leveraging Social Media for Professional Growth and Networking
Rick Buck, Chief Communications Officer/Vice President of Communications and Public Relations at AACR, shared on X:
“My friend and partner in cancer research social media Vivek Subbiah is presenting on Leveraging Social Media for Professional Growth and Networking at the AACR Grantee Summit. Thank you for rearranging your schedule to present today!”
More posts featuring Vivek Subbiah on oncodaily.com
Vivek Subbiah is the Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA). He is the former Executive Director of Oncology Research and former Associate Professor in the Department of Investigational Cancer Therapeutics at the MD Anderson Cancer He focuses on translational cancer research and the design and implementation of early-phase biomarker-driven clinical trials. His work specifically targets antibody-drug conjugates, radiopharmaceuticals, immunoconjugates, and basket trials.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023